Research
1. Applications of Artificial Intelligence in Coloproctology
2. Role of microbiome / metabolome in predicting response to treatment in colorectal cancer
3. Understanding the role of tumour microenvironment in predicting response to neoadjuvant treatment in rectal cancer
Research grants
Evaluating the role of faecal microbiome in assessing response to neoadjuvant treatment, surveillance and nutritional prehabilitation in colorectal cancer
BOWEL RESEARCH UK
July 2025 - June 2027
Pilot study evaluating the role of diet and faecal microbiome in predicting response to contact radiotherapy in patients with rectal cancer
GUTS (UK CHARITY)
June 2025 - May 2027
A Multimodal Predictive Model using Artificial Intelligence for Predicting Response to Chemoradiotherapy in Rectal Cancer
LIVERPOOL UNIVERSITY HOSPITALS NHS FOUNDATION TRUST (UK)
January 2025 - December 2026
NWCR Bench Fees
NORTH WEST CANCER RESEARCH INCORPORATING CLATTERBRIDGE CANCER RESEARCH (UK)
August 2024 - August 2026
Molecular evolution of rectal cancer and prediction of response
ROYAL LIVERPOOL AND BROADGREEN UNIVERSITY HOSPITALS NHS TRUST CHARITABLE FUNDS (UK)
June 2023 - December 2025
Mitochondrial cyclophilin D: a novel molecular target for treatment of necrotizing pancreatitis
GUTS (UK CHARITY)
August 2011 - July 2014
Evaluating TR040303 as a potential treatment of necrotizing pancreatitis
ROYAL COLLEGE OF SURGEONS OF ENGLAND(UK)
August 2013 - July 2014